According to Medigene AG's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.1498. At the end of 2024 the company had a P/S ratio of 4.39.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.39 | -20.06% |
2023 | 5.50 | 7.12% |
2022 | 5.13 | -52.55% |
2021 | 10.8 | -3.95% |
2020 | 11.3 | 22.21% |
2019 | 9.21 | -68.86% |
2018 | 29.6 | 13.92% |
2017 | 26.0 | 11.04% |
2016 | 23.4 | -5.85% |
2015 | 24.8 | 601.53% |
2014 | 3.54 | -24.75% |
2013 | 4.70 | -21.77% |
2012 | 6.01 | 9.39% |
2011 | 5.50 | |
2010 | N/A |